MedTrace to partner with Mayo Clinic in oncology study

MedTrace to partner with Mayo Clinic in oncology study As part of the recently closed equity fundraising, MedTrace also signed a know-how license agreement with Mayo Clinic (Rochester, MN, USA) embarking on the already installed P3 prototype and the aQuant software. The scope of the agreement is outlined in the press release below. Press Release […]

MedTrace feature article in Børsen

MedTrace feature article in Børsen MedTrace is proud to see a feature article in Børsen (May 26th, 2020), Denmarks leading business newspaper. CEO Martin Stenfeldt was interviewed about the latest progress, the next steps and his view on market launch estimates as well as exit opportunities. The article requires a subscription to Børsen to access […]

MedTrace accomplishes funding of DKK 21M

MedTrace accomplishes funding of DKK 21M MedTrace Pharma A/S has completed a capital raise against equity to advance our preparations for the upcoming clinical trial phase III. Three new investors have injected cash into MedTrace along with current investors and loans have been converted to new share capital. The proceeds extend the company’s runway well […]

Putting the low radiation dose of 15O-water in perspective

Putting the low radiation of 15O-water in perspective Tracers are radioactive compounds that doctors inject into patients to diagnose various diseases by, for example, following the flow of blood or use of sugar in organs. All tracers come with a radiation dose, but the dose of 15O-water is much lower than all other tracers used […]

Manufacturing Partnership

Manufacturing Partnership with A/S Kurt Hansen In preparation for our future production of hardware systems, we have partnered with A/S Kurt Hansen from Svendborg, Denmark to manufacture the next five P3 prototype systems. Planned delivery for the first system is first week of December whereas the last unit is planned to be delivered in early […]

ASNC Young Investigator’s Award

Hans receives the Young Investigator’s Award at ASNC Hans Harms, our VP of Software Development, received the Young Investigator’s Award at the ASNC meeting this year. The distinguished prize was awarded for his presentation of the study “Elevated Right-Ventricular Blood Flow is Associated with Diastolic Dysfunction and Adverse Cardiovascular Events, Including Heart Failure with Preserved […]

Japanese Country Manager

Japanese Country Manager on board Since the beginning of our activities in Japan, we have had the pleasure of working together with Yumi Murakami from the Danish Embassy in Tokyo. She has since left the embassy and we have been able to engage her part-time to function as Country Manager for our Japanese activities. Her […]

SNMMI Conference

MedTrace Pharma Exhibits at SNMMI The annual meeting of the Society of Nuclear Medicine and Molecular Imaging (#SNMMI) takes place in Anaheim, California this year on June 22-25. Each year the event attracts more than 5,000 participants from all over the world representing hospitals, academia and industry. MedTrace participates this year with a small booth […]

Visit from Japan

Visit from Japan In the beginning of June, a small delegation from Japan visited MedTrace to get a demo of the P3 installation in Aarhus. The chief chemist of Osaka University Hospital, Dr. Sadahiro Naka was accompanied by Dr. Katayama from the nuclear medicine department. In addition, Sumitomo Heavy Industries (SHI) had sent one of […]